EC Number | Cloned (Comment) | Organism |
---|---|---|
1.1.5.4 | overexpression in an Escherichia coli BL21Star(DE3) | Plasmodium falciparum |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.5.4 | ferulenol | inhibits parasite growth and shows strong synergism in combination with atovaquone, an anti-malarial and bc1 complex inhibitor | Plasmodium falciparum |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.1.5.4 | 0.0062 | - |
decylubiquinone | pH 7.0, 37°C | Plasmodium falciparum | |
1.1.5.4 | 5.99 | - |
(S)-malate | pH 7.0, 37°C | Plasmodium falciparum |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.1.5.4 | membrane | membrane bound | Plasmodium falciparum | 16020 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.5.4 | (S)-malate + ubiquinone | Plasmodium falciparum | the enzyme is involved in three pathways (mitochondrial electron transport chain, the tricarboxylic acid cycle and the fumarate cycle) | oxaloacetate + ubiquinol | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.5.4 | Plasmodium falciparum | C6KT09 | isolate 3D7 | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.5.4 | (S)-malate + decylubiquinone | - |
Plasmodium falciparum | oxaloacetate + decylubiquinol | - |
? | |
1.1.5.4 | (S)-malate + ubiquinone | the enzyme is involved in three pathways (mitochondrial electron transport chain, the tricarboxylic acid cycle and the fumarate cycle) | Plasmodium falciparum | oxaloacetate + ubiquinol | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.5.4 | L-malate:quinone oxidoreductase | - |
Plasmodium falciparum |
1.1.5.4 | PfMQO | - |
Plasmodium falciparum |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.1.5.4 | 37 | - |
- |
Plasmodium falciparum |
EC Number | Temperature Minimum [°C] | Temperature Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.1.5.4 | 25 | 40 | 25-30°C: about 50% of maximal activity, 40°C: about 90% of maximal activity | Plasmodium falciparum |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.1.5.4 | 7.3 | - |
- |
Plasmodium falciparum |
EC Number | pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|---|
1.1.5.4 | 6.8 | 8.2 | no significant difference in activity from pH 6.8 to 8.2 | Plasmodium falciparum |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.1.5.4 | 0.00925 | - |
pH 7.0, 37°C | Plasmodium falciparum | ferulenol |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.1.5.4 | drug target | the enzyme is a potential antimalarial drug target against the apicomplexan parasite Plasmodium falciparum, because the enzyme is absent in humans. Ferulenol inhibits parasite growth and shows strong synergism in combination with atovaquone, an anti-malarial and bc1 complex inhibitor | Plasmodium falciparum |
1.1.5.4 | metabolism | the enzyme is involved in three pathways (mitochondrial electron transport chain, the tricarboxylic acid cycle and the fumarate cycle) | Plasmodium falciparum |
1.1.5.4 | physiological function | the enzyme is essential for parasite survival, at least, in the intra-erythrocytic asexual stage | Plasmodium falciparum |